Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | [email protected]

Newsroom Search

featured news

August 20, 2014 Healthcare Fraud

UPDATE: U.S. Government Opts to Intervene in New York False Claims Act Case Against Continuum Health

Earlier this year, we reported on a False Claims Act case filed in the State of New York under its state level False Claims Act, which was then joined by the New York Attorney General’s Office. The case, which involves Continuum Health Partners and affiliated Mt. Sinai Health System, has […]
August 18, 2014 Healthcare Fraud

Infirmary Health, Inc. Agrees to Pay $24.5 Million to Settle False Claims Act Allegations

In a press release issued by the U.S. Department of Justice late last month, Mobile, Alabama-based Infirmary Health, Inc. has agreed to pay over $24 million to settle claims it engaged in unlawful kickback schemes and fraudulent conduct in violation of the False Claims Act. The allegations specifically address unlawful […]
August 8, 2014 Healthcare Fraud

Vascular Solutions to Pay $520,000 to Settle False Claims Act Allegations

In a recent False Claims Act settlement, Minneapolis-based Vascular Solutions, Inc. (“VSI”) has agreed to pay $520,000 to the federal government in order to settle claims it unlawfully marketed its products for the treatment of varicose veins. The company, which has admitted no liability or guilt in the matter, agreed […]
July 30, 2014 Healthcare Fraud

Off-Label Marketing Case Involving Calgene Survives Despite Defendants’ Motion to Dismiss

Earlier this month, a False Claims Act case against drug maker Calgene was unsealed, revealing allegations of off-label marketing with regard to its controversial cancer drug Thalomid. The case, in which the government opted not to intervene, has been subject to several months’ worth of procedural wrangling by both parties. […]
July 28, 2014 Healthcare Fraud

American International Biotechnology to Settle False Claims Act Allegations for Nearly $350,000

In an interesting False Claims Act case involving government contracts concerning biotechnology, Virginia-based American International Biotechnology reportedly defrauded the federal government by improperly billing for genetic testing. The case involves the widespread problem of fraud against Medicare and Medicaid, and reveals the true extent to which healthcare fraud is invading […]
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

in Settlements & Verdicts
Years of High-Profile Cases
Attorneys Protecting Your Rights
Named “Trial Lawyer of the Year”
States in Which The Firm Has Successfully Litigated Cases

On the Cutting Edge of the Profession

Legal Intelligencer